Skip to main content
Erschienen in: International Urology and Nephrology 6/2012

01.12.2012 | Nephrology - Review

Proteinuria in the elderly: evaluation and management

verfasst von: Vipin Verma, Ravi Kant, Naseem Sunnoqrot, Steven R. Gambert

Erschienen in: International Urology and Nephrology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

While aging is accompanied by many age-related changes in renal physiology and function, proteinuria should not be considered to be a part of “normal aging”. There are many age-prevalent illnesses that predispose one to developing proteinuria and early recognition, and treatment may help retard disease progression or offer an early cure. The presence of proteinuria warrants further evaluation and follow-up if one has any hope of avoiding its progression and delaying the initiation of treatment. This review article will discuss the anatomy and physiology of the aging kidney, the pathophysiology and etiology of proteinuria during later life, methods to evaluate proteinuria, and ways to monitor and manage this problem.
Literatur
1.
Zurück zum Zitat Lindeman RD, Tobin J, Shock NW (1985) Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:278–285PubMed Lindeman RD, Tobin J, Shock NW (1985) Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:278–285PubMed
2.
Zurück zum Zitat Levey AS, Coresh J et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139(2):137–147PubMed Levey AS, Coresh J et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139(2):137–147PubMed
3.
Zurück zum Zitat Carroll MF, Temte JL (2000) Proteinuria in adults: a diagnostic approach. Am Fam Phys 62(6):1333–1340 Carroll MF, Temte JL (2000) Proteinuria in adults: a diagnostic approach. Am Fam Phys 62(6):1333–1340
4.
Zurück zum Zitat Oni MO, Oguntibeju OO (2008) Clinical and diagnostic importance of proteinuria: a review. Afr J Biotechnol 7(18):3166–3172 Oni MO, Oguntibeju OO (2008) Clinical and diagnostic importance of proteinuria: a review. Afr J Biotechnol 7(18):3166–3172
5.
Zurück zum Zitat Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J (2008) Harrison's principles of internal medicine, 17th edn. McGraw-Hill Medical Publishing Division, New York. ISBN 978-0-07-146633-2 Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J (2008) Harrison's principles of internal medicine, 17th edn. McGraw-Hill Medical Publishing Division, New York. ISBN 978-0-07-146633-2
6.
Zurück zum Zitat Christensen EI, Birn H (2001) Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol 280(4):F562–F573PubMed Christensen EI, Birn H (2001) Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol 280(4):F562–F573PubMed
7.
Zurück zum Zitat Glassock RJ, Rule AD (2012) The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int. doi:10.1038/ki.2012.65 Glassock RJ, Rule AD (2012) The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int. doi:10.​1038/​ki.​2012.​65
8.
Zurück zum Zitat Lorenz EC, Lieske JC, Vrtiska TJ et al (2011) Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 26:2695–2700PubMedCrossRef Lorenz EC, Lieske JC, Vrtiska TJ et al (2011) Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 26:2695–2700PubMedCrossRef
9.
Zurück zum Zitat Rowe JW, Andres R, Tobin JD et al (1976) The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31:155–163PubMedCrossRef Rowe JW, Andres R, Tobin JD et al (1976) The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31:155–163PubMedCrossRef
10.
Zurück zum Zitat Hemmelgarn BR, Manns BJ et al (2010) Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303(5):423–429PubMedCrossRef Hemmelgarn BR, Manns BJ et al (2010) Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303(5):423–429PubMedCrossRef
11.
Zurück zum Zitat Ballard DJ, Humphrey LL, Melton LJ III, Frohnert PP, Chu PC, O’Fallon WM, Palumbo PJ (1988) Epidemiology of persistent proteinuria in type II diabetes mellitus: population-based study in Rochester. Minn Diabetes 37:405–412 Ballard DJ, Humphrey LL, Melton LJ III, Frohnert PP, Chu PC, O’Fallon WM, Palumbo PJ (1988) Epidemiology of persistent proteinuria in type II diabetes mellitus: population-based study in Rochester. Minn Diabetes 37:405–412
12.
Zurück zum Zitat Araki A, Ito H, Hattori A et al (1993) Risk factors for development of retinopathy in elderly Japanese patients with diabetes mellitus. Diabetes Care 16:1184–1186PubMedCrossRef Araki A, Ito H, Hattori A et al (1993) Risk factors for development of retinopathy in elderly Japanese patients with diabetes mellitus. Diabetes Care 16:1184–1186PubMedCrossRef
13.
Zurück zum Zitat Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361:117–124 (CrossRef Medline)PubMedCrossRef Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361:117–124 (CrossRef Medline)PubMedCrossRef
14.
Zurück zum Zitat Mann JFE, Schmieder RE, McQueen M et al (2008) Renal outcomes with telmisartan, ramipril, or both in people at high vascular risk (the ONTARGET study): a multicentre, randomized, double-blind controlled trial. Lancet 372:547–553PubMedCrossRef Mann JFE, Schmieder RE, McQueen M et al (2008) Renal outcomes with telmisartan, ramipril, or both in people at high vascular risk (the ONTARGET study): a multicentre, randomized, double-blind controlled trial. Lancet 372:547–553PubMedCrossRef
15.
Zurück zum Zitat Kyle RA (2009) Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Hematol Oncol Clin N Am 11(1):71–87CrossRef Kyle RA (2009) Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Hematol Oncol Clin N Am 11(1):71–87CrossRef
16.
Zurück zum Zitat Smith A, Wisloff F, Samson D et al (2006) Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 132(4):410–451 Smith A, Wisloff F, Samson D et al (2006) Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 132(4):410–451
17.
Zurück zum Zitat Oreopoulos DG, Hazzard WR et al. (1998) Nephrology and geriatrics integrated. In: Proceedings of the conference on integrating geriatrics into nephrology held in Jasper, Alberta, July 31–Aug 5 Oreopoulos DG, Hazzard WR et al. (1998) Nephrology and geriatrics integrated. In: Proceedings of the conference on integrating geriatrics into nephrology held in Jasper, Alberta, July 31–Aug 5
18.
Zurück zum Zitat Eknoyan G, Hostetter T et al (2003) Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 42(4):617–622PubMedCrossRef Eknoyan G, Hostetter T et al (2003) Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 42(4):617–622PubMedCrossRef
19.
Zurück zum Zitat National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266 National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266
20.
Zurück zum Zitat Price CP, Newall RG, Boyd JC (2005) Use of protein: creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem 51:1577–1586PubMedCrossRef Price CP, Newall RG, Boyd JC (2005) Use of protein: creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem 51:1577–1586PubMedCrossRef
21.
Zurück zum Zitat Polkinghorne KR (2006) Detection and measurement of urinary protein. Curr Opin Nephrol Hypertens 15(6):625–630PubMedCrossRef Polkinghorne KR (2006) Detection and measurement of urinary protein. Curr Opin Nephrol Hypertens 15(6):625–630PubMedCrossRef
22.
Zurück zum Zitat Presta P, Lucisano G et al (2012) The kidney and the elderly: why does the risk increase? Int Urol Nephrol 44(2):625–632 Epub 2011 Oct 14PubMedCrossRef Presta P, Lucisano G et al (2012) The kidney and the elderly: why does the risk increase? Int Urol Nephrol 44(2):625–632 Epub 2011 Oct 14PubMedCrossRef
Metadaten
Titel
Proteinuria in the elderly: evaluation and management
verfasst von
Vipin Verma
Ravi Kant
Naseem Sunnoqrot
Steven R. Gambert
Publikationsdatum
01.12.2012
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 6/2012
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0252-7

Weitere Artikel der Ausgabe 6/2012

International Urology and Nephrology 6/2012 Zur Ausgabe

Nephrology - Review

The kidney in space

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.